These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17378544)

  • 1. Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
    Adachi H; Palaniappan KK; Ivanov AA; Bergman N; Gao ZG; Jacobson KA
    J Med Chem; 2007 Apr; 50(8):1810-27. PubMed ID: 17378544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A2B adenosine receptor agonists: synthesis and biological evaluation of 2-phenylhydroxypropynyl adenosine and NECA derivatives.
    Vittori S; Costanzi S; Lambertucci C; Portino FR; Taffi S; Volpini R; Klotz KN; Cristalli G
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):471-81. PubMed ID: 15043167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of truncated C2- or C8-substituted adenosine derivatives as dual acting A₂A and A₃ adenosine receptor ligands.
    Hou X; Majik MS; Kim K; Pyee Y; Lee Y; Alexander V; Chung HJ; Lee HW; Chandra G; Lee JH; Park SG; Choi WJ; Kim HO; Phan K; Gao ZG; Jacobson KA; Choi S; Lee SK; Jeong LS
    J Med Chem; 2012 Jan; 55(1):342-56. PubMed ID: 22142423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional screening of adenosine analogues at the adenosine A2B receptor: a search for potent agonists.
    de Zwart M; Link R; von Frijtag Drabbe Künzel JK; Cristalli G; Jacobson KA; Townsend-Nicholson A; IJzerman AP
    Nucleosides Nucleotides; 1998 Jun; 17(6):969-85. PubMed ID: 9708319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling.
    Vecchio EA; Chuo CH; Baltos JA; Ford L; Scammells PJ; Wang BH; Christopoulos A; White PJ; May LT
    Biochem Pharmacol; 2016 Oct; 117():46-56. PubMed ID: 27520486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.
    Tchilibon S; Joshi BV; Kim SK; Duong HT; Gao ZG; Jacobson KA
    J Med Chem; 2005 Mar; 48(6):1745-58. PubMed ID: 15771421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capadenoson, a clinically trialed partial adenosine A
    Baltos JA; Vecchio EA; Harris MA; Qin CX; Ritchie RH; Christopoulos A; White PJ; May LT
    Biochem Pharmacol; 2017 Jul; 135():79-89. PubMed ID: 28344125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors.
    Gao ZG; Mamedova LK; Chen P; Jacobson KA
    Biochem Pharmacol; 2004 Nov; 68(10):1985-93. PubMed ID: 15476669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors.
    van Tilburg EW; van der Klein PA; von Frijtag Drabbe Künzel J; de Groote M; Stannek C; Lorenzen A; IJzerman AP
    J Med Chem; 2001 Aug; 44(18):2966-75. PubMed ID: 11520205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
    Volpini R; Dal Ben D; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
    J Med Chem; 2007 Mar; 50(6):1222-30. PubMed ID: 17309246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2,8-Disubstituted adenosine derivatives as partial agonists for the adenosine A2A receptor.
    van Tilburg EW; Gremmen M; von Frijtag Drabbe Künzel J; de Groote M; IJzerman AP
    Bioorg Med Chem; 2003 May; 11(10):2183-92. PubMed ID: 12713828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel 1-deoxy-1-[6-[((hetero)arylcarbonyl)hydrazino]- 9H-purin-9-yl]-N-ethyl-beta-D-ribofuranuronamide derivatives as useful templates for the development of A2B adenosine receptor agonists.
    Baraldi PG; Preti D; Tabrizi MA; Fruttarolo F; Romagnoli R; Carrion MD; Cara LC; Moorman AR; Varani K; Borea PA
    J Med Chem; 2007 Jan; 50(2):374-80. PubMed ID: 17228880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands.
    Volpini R; Costanzi S; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
    J Med Chem; 2002 Jul; 45(15):3271-9. PubMed ID: 12109910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists.
    Pal S; Choi WJ; Choe SA; Heller CL; Gao ZG; Chinn M; Jacobson KA; Hou X; Lee SK; Kim HO; Jeong LS
    Bioorg Med Chem; 2009 May; 17(10):3733-8. PubMed ID: 19375920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
    Klotz KN; Hessling J; Hegler J; Owman C; Kull B; Fredholm BB; Lohse MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):1-9. PubMed ID: 9459566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A₂A adenosine receptor.
    Deflorian F; Kumar TS; Phan K; Gao ZG; Xu F; Wu H; Katritch V; Stevens RC; Jacobson KA
    J Med Chem; 2012 Jan; 55(1):538-52. PubMed ID: 22104008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Phenylhydroxypropynyladenosine derivatives as high potent agonists at A2B adenosine receptor subtype.
    Lambertucci C; Volpini R; Costanzi S; Taffi S; Vittori S; Cristalli G
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):809-12. PubMed ID: 14565284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors.
    Gao ZG; Blaustein JB; Gross AS; Melman N; Jacobson KA
    Biochem Pharmacol; 2003 May; 65(10):1675-84. PubMed ID: 12754103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological activity of N6-substituted-4'-thioadenosines at the human A3 adenosine receptor.
    Jeong LS; Lee HW; Kim HO; Jung JY; Gao ZG; Duong HT; Rao S; Jacobson KA; Shin DH; Lee JA; Gunaga P; Lee SK; Jin DZ; Chun MW; Moon HR
    Bioorg Med Chem; 2006 Jul; 14(14):4718-30. PubMed ID: 16603368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation.
    Vecchio EA; Tan CY; Gregory KJ; Christopoulos A; White PJ; May LT
    J Pharmacol Exp Ther; 2016 Apr; 357(1):36-44. PubMed ID: 26791603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.